Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department

Respiratory Care

Volumn 56, Issue 3, 2011, Pages 314-318

  Coates, Allan L ^a   Leung, Kitty ^a   Vecellio, Laurent ^c   Schuh, Suzanne ^b  

^a Department of Physiology and Experimental Medicine ^*  (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Aerosol delivery; Asthma; Magnesium sulfate; Nebulizer; Pulmonary deposition

Indexed keywords

MAGNESIUM SULFATE; SALBUTAMOL;

AEROSOL; ARTICLE; ASTHMA; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREATHING PATTERN; CHILD HEALTH CARE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; EMERGENCY CARE; EMERGENCY WARD; EQUIPMENT DESIGN; FACE MASK; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; MATERIALS TESTING; MEDICAL NEBULIZER; NEBULIZATION; PARTICLE SIZE; PILOT STUDY; PREDICTION; QUALITY CONTROL;

ADMINISTRATION, INHALATION; ADOLESCENT; AEROSOLS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; HUMANS; MAGNESIUM SULFATE; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS;

EID: 79953135672     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00826     Document Type: Article

References (29)

1. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92(4):513-518.
2. Becker A, Lemière C, Bérubé D, Boulet LP, Ducharme FM, FitzGerald M, Kovesi T; Asthma Guidelines Working Group of the Canadian Network For Asthma Care. Summary of recommendations from the Canadian asthma consensus guidelines, 2003. CMAJ Can Med Assoc J 2005;173(6 Suppl):S3-S11.
3. Kercsmar CM, McDowell KM. Love it or lev it: levalbuterol for severe acute asthma: for now, leave it. J Pediatrics 2009;155(2):162-164.
4. Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med 1981;305(14):783-789.
5. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000;106(3):493-499.
6. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematc review and meta-analysis. Emerg Med J 2007;24(12):832-830.
7. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005; 90(1):74-77.
8. Aggarwal P, Sharad S, Handa R, Dwiwedi SN, Irshad M. Comparison of nebulised magnesium sulfate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomised study. Emerg Med J 2006;23(5):358-362.
9. Schuh S, Macias C, Freedman S, Plint A, Zorc J, Baja JL, et al. North American practice patterns of IV magnesium therapy in severe acute asthma in children. Acad Emerg Med 2010;17(11):1189-1196.
10. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA 1987;257(8):1076-1078.
11. Blitz M, Blitz S, Beasely R, Diner BM, Hughes R, Knopp JA, Rowe BH. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005;(4):CD003898.
12. Villeneuve EJ, Zed PJ. Nebulized magnesium sulfate in the management of acute exacerbations of asthma. Ann Pharmacother 2006; 40(6):1118-1124.
13. Dodd ME, Abbott J, Maddison J, Moorcroft AJ, Webb AK. Effect of tonicity of nebulized colistin on chest tightness and pulmonary function in adults with cystic fibrosis. Thorax 1997;52(7):656-658.
14. Ho SL, Kwong WTJ, Coates AL. Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med 2001(4):14:467-475.
15. Katz SL, Adatia I, Louca E, Leung K, Humpl T, Reyes JT, Coates AL. Nebulized therapy for childhood pulmonary hypertension: an in vitro model. Pediatr Pulmonol 2006;41(7):666-673.
16. O'Callaghan C, Clarke AR, Milner AD. Inaccurate calculation of drug output from nebulisers. Eur J Pediatr 1989;148(5):473-474.
17. Coates AL, MacNeish CF, Lands LC, Smountas A, Meisner D, Kelemen S, Vadas EB. Factors influencing the rate of drug output during the course of wet nebulization. J Aerosol Med 1998;11(2): 101-111.
18. Coates AL, MacNeish CF, Allen PD, Ho SL, Lands LC. Do sinusoidal models of respiration accurately reflect the respiratory events of cystic fibrosis patients breathing on nebulizers? J Aerosol Med 1999;12(4):265-273.
19. Leung K, Louca E, Coates AL. Comparison of breath enhanced to breath actuated nebulizers for rate, consistency, and efficiency. Chest 2004;126(5):1619-1627.
20. Coates AL, Tipples G, Leung K, Gray M, Louca E; WHO Product Development Group for Measles Aerosol Vaccine. How many infective particles are necessary for successful mass measles immunization by aerosol? Vaccine 2006;24(10):1578-1585.
21. Mitchell JP, Nagel MW, Nichols S, Nerbrink O. Laser diffractometry as a technique for rapid assessment of aerosol particle size from inhalers. J Aerosol Med 2006;19(4):409-433.
22. Coates AL, MacNeish CF, Meisner D, Kelemen S, Thibert R, Mac-Donald J, Vadas EB. The choice of jet nebulizer, nebulizing flow and the addition of Ventolin respiratory solution affects tobramycin aerosols used in cystic fibrosis. Chest 1997;111(5):1206-1212.
23. MacNeish CF, Meisner D, Thibert R, Kelemen S, Vadas EB, Coates AL. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution. Chest 1997;111(1):204-208.
24. Newman SP, Pellow PG, Clay MM, Clarke SW. Evaluation of jet nebulisers for use with gentamycin solution. Thorax 1985;40(9):671-676.
25. Clay MM, Pavia D, Newman SP, Clarke SW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983;38(10): 755-759.
26. Janssens HM, de Jongste JC, Fokkens WJ, Robben SG, Wouters K, Tiddens HA. The Sophia anatomical infant nose-throat (SAINT) model: a valuable tool to study aerosol deposition in infants. J Aerosol Med 2001;14(4):433-441.
27. Ciarallo L, Brousseau D, Reinert S. Higher dose intravenous magnesium sulfate therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000;154(10):979-983.
28. Coates AL, MacNeish CF, Dinh L, Rollin T, Gagnon S, Ho SL, Lands LC. Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition. J Aerosol Med 2000;13(3):169-178.
29. Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, et al. The challenges of quantitative measurement of lung deposition using 99mTc-DTPAfrom delivery systems with very different delivery times. J Aerosol Med 2007;20(3):320-330.